These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 37609807)

  • 21. Comparison of the Pathogenicity of SARS-CoV-2 Delta and Omicron Variants by Analyzing the Expression Patterns of Immune Response Genes in K18-hACE2 Transgenic Mice.
    Kuruppuarachchi KAPP; Jang Y; Seo SH
    Front Biosci (Landmark Ed); 2022 Nov; 27(11):316. PubMed ID: 36472114
    [TBL] [Abstract][Full Text] [Related]  

  • 22. RBD-VLP Vaccines Adjuvanted with Alum or SWE Protect K18-hACE2 Mice against SARS-CoV-2 VOC Challenge.
    Wong TY; Russ BP; Lee KS; Miller OA; Kang J; Cooper M; Winters MT; Rodriguez-Aponte SA; Dalvie NC; Johnston RS; Rader NA; Wong ZY; Cyphert HA; Martinez I; Shaligram U; Batwal S; Lothe R; Chandrasekaran R; Nagar G; Rajurkar M; Rao H; Bevere JR; Barbier M; Love JC; Damron FH
    mSphere; 2022 Aug; 7(4):e0024322. PubMed ID: 35968964
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cutting Edge: Characterization of Low Copy Number Human Angiotensin-Converting Enzyme 2-Transgenic Mice as an Improved Model of SARS-CoV-2 Infection.
    Bradshaw CM; Georgieva T; Tankersley TN; Taylor-Doyle T; Johnson L; Uhrlaub JL; Besselsen D; Nikolich JŽ
    J Immunol; 2024 Feb; 212(4):523-528. PubMed ID: 38197714
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Temporal Transcriptome Analysis of SARS-CoV-2-Infected Lung and Spleen in Human ACE2-Transgenic Mice.
    Kim JA; Kim SH; Seo JS; Noh H; Jeong H; Kim J; Jeon D; Kim JJ; On D; Yoon S; Lee SG; Lee YW; Jang HJ; Park IH; Oh J; Seok SH; Lee YJ; Hong SM; An SH; Bae JY; Choi JA; Kim SY; Kim YB; Hwang JY; Lee HJ; Kim HB; Jeong DG; Song D; Song M; Park MS; Choi KS; Park JW; Yun JW; Shin JS; Lee HY; Seo JY; Nam KT; Gee HY; Seong JK
    Mol Cells; 2022 Dec; 45(12):896-910. PubMed ID: 36324270
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intranasal inoculation of an MVA-based vaccine induces IgA and protects the respiratory tract of hACE2 mice from SARS-CoV-2 infection.
    Americo JL; Cotter CA; Earl PL; Liu R; Moss B
    Proc Natl Acad Sci U S A; 2022 Jun; 119(24):e2202069119. PubMed ID: 35679343
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Abundant Distribution and Duplication of SARS-CoV-2 in the Cerebrum and Lungs Promote a High Mortality Rate in Transgenic hACE2-C57 Mice.
    Li H; Zhao X; Peng S; Li Y; Li J; Zheng H; Zhang Y; Zhao Y; Tian Y; Yang J; Wang Y; Zhang X; Liu L
    Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38256071
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Contribution of SARS-CoV-2 Accessory Proteins to Viral Pathogenicity in K18 Human ACE2 Transgenic Mice.
    Silvas JA; Vasquez DM; Park JG; Chiem K; Allué-Guardia A; Garcia-Vilanova A; Platt RN; Miorin L; Kehrer T; Cupic A; Gonzalez-Reiche AS; Bakel HV; García-Sastre A; Anderson T; Torrelles JB; Ye C; Martinez-Sobrido L
    J Virol; 2021 Aug; 95(17):e0040221. PubMed ID: 34133899
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Highly susceptible SARS-CoV-2 model in CAG promoter-driven hACE2-transgenic mice.
    Asaka MN; Utsumi D; Kamada H; Nagata S; Nakachi Y; Yamaguchi T; Kawaoka Y; Kuba K; Yasutomi Y
    JCI Insight; 2021 Oct; 6(19):. PubMed ID: 34463644
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mice humanized for MHC and hACE2 with high permissiveness to SARS-CoV-2 omicron replication.
    Le Chevalier F; Authié P; Chardenoux S; Bourgine M; Vesin B; Cussigh D; Sassier Y; Fert I; Noirat A; Nemirov K; Anna F; Bérard M; Guinet F; Hardy D; Charneau P; Lemonnier F; Langa-Vives F; Majlessi L
    Microbes Infect; 2023; 25(7):105142. PubMed ID: 37080384
    [TBL] [Abstract][Full Text] [Related]  

  • 30. K18-hACE2 mice develop respiratory disease resembling severe COVID-19.
    Yinda CK; Port JR; Bushmaker T; Offei Owusu I; Purushotham JN; Avanzato VA; Fischer RJ; Schulz JE; Holbrook MG; Hebner MJ; Rosenke R; Thomas T; Marzi A; Best SM; de Wit E; Shaia C; van Doremalen N; Munster VJ
    PLoS Pathog; 2021 Jan; 17(1):e1009195. PubMed ID: 33465158
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SARS-CoV-2 variants of concern display enhanced intrinsic pathogenic properties and expanded organ tropism in mouse models.
    Stolp B; Stern M; Ambiel I; Hofmann K; Morath K; Gallucci L; Cortese M; Bartenschlager R; Ruggieri A; Graw F; Rudelius M; Keppler OT; Fackler OT
    Cell Rep; 2022 Feb; 38(7):110387. PubMed ID: 35134331
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SARS-CoV-2 Delta variant induces enhanced pathology and inflammatory responses in K18-hACE2 mice.
    Lee KS; Wong TY; Russ BP; Horspool AM; Miller OA; Rader NA; Givi JP; Winters MT; Wong ZYA; Cyphert HA; Denvir J; Stoilov P; Barbier M; Roan NR; Amin MS; Martinez I; Bevere JR; Damron FH
    PLoS One; 2022; 17(8):e0273430. PubMed ID: 36037222
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intranasal administration of a single dose of MVA-based vaccine candidates against COVID-19 induced local and systemic immune responses and protects mice from a lethal SARS-CoV-2 infection.
    Pérez P; Astorgano D; Albericio G; Flores S; Sánchez-Cordón PJ; Luczkowiak J; Delgado R; Casasnovas JM; Esteban M; García-Arriaza J
    Front Immunol; 2022; 13():995235. PubMed ID: 36172368
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of Three Variants of SARS-CoV-2 In Vivo Shows Host-Dependent Pathogenicity in Hamsters, While Not in K18-hACE2 Mice.
    Toomer G; Burns W; Garcia L; Henry G; Biancofiori A; George A; Duffy C; Chu J; Sides M; Muñoz M; Garcia K; Nikolai-Yogerst A; Peng X; Westfall L; Baker R
    Viruses; 2022 Nov; 14(11):. PubMed ID: 36423193
    [TBL] [Abstract][Full Text] [Related]  

  • 35. C57BL/6J Mice Are Not Suitable for Modeling Severe SARS-CoV-2 Beta and Gamma Variant Infection.
    Currey JM; Rabito F; Maness NJ; Blair RV; Rappaport J; Qin X; Kolls JK; Srivastava AK
    Viruses; 2022 May; 14(5):. PubMed ID: 35632708
    [TBL] [Abstract][Full Text] [Related]  

  • 36. K18- and CAG-hACE2 Transgenic Mouse Models and SARS-CoV-2: Implications for Neurodegeneration Research.
    Dedoni S; Avdoshina V; Camoglio C; Siddi C; Fratta W; Scherma M; Fadda P
    Molecules; 2022 Jun; 27(13):. PubMed ID: 35807384
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Early pathogenesis profiles across SARS-CoV-2 variants in K18-hACE2 mice revealed differential triggers of lung damages.
    Aw ZQ; Mok CK; Wong YH; Chen H; Mak TM; Lin RTP; Lye DC; Tan KS; Chu JJH
    Front Immunol; 2022; 13():950666. PubMed ID: 36389747
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Baculoviral COVID-19 Delta DNA vaccine cross-protects against SARS-CoV2 variants in K18-ACE2 transgenic mice.
    Jang Y; Cho H; Chun J; Park K; Nowakowska A; Kim J; Lee H; Lee C; Han Y; Lee HJ; Shin HY; Kim YB
    Vaccine; 2023 Feb; 41(6):1223-1231. PubMed ID: 36631359
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neuroinvasion and Encephalitis Following Intranasal Inoculation of SARS-CoV-2 in K18-hACE2 Mice.
    Kumari P; Rothan HA; Natekar JP; Stone S; Pathak H; Strate PG; Arora K; Brinton MA; Kumar M
    Viruses; 2021 Jan; 13(1):. PubMed ID: 33477869
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Proteomic and phosphoproteomic characteristics of the cortex, hippocampus, thalamus, lung, and kidney in COVID-19-infected female K18-hACE2 mice.
    Liu JF; Peng WJ; Wu Y; Yang YH; Wu SF; Liu DP; Liu JN; Yang JT
    EBioMedicine; 2023 Apr; 90():104518. PubMed ID: 36933413
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.